Utah Colorado Biotech Networks
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All News
    • UCBN Trending News
  • Jobs
    • All Jobs
    • Submit a Job
  • Advertise
  • BN Connect
    • BN Connect
    • About Biotech Networks Connect
  • Subscribe
  • Contact
News Ticker
  • [ August 21, 2026 ] Part-time Open Rank Research Services Laboratory Services Professional (Entry – Intermediate) (0.5 FTE) – Aurora, CO Jobs
  • [ August 20, 2026 ] Oncology Account Executive – Salt Lake City, UT Jobs
  • [ August 20, 2026 ] Bucked Up® Launches Hunt: Orange Cream, a Limited-Edition Flavor Built to Fuel Your Hunt News
  • [ August 20, 2026 ] New NCCI data analysis confirms Pinnacol Assurance has fastest, most accurate claims handling in Colorado News
  • [ August 20, 2026 ] Engineer 2 – Human Factors – Lakewood, CO Jobs
HomeNewsSTAT+: AI drug developers Recursion, Exscientia to merge

STAT+: AI drug developers Recursion, Exscientia to merge

August 8, 2024 UCBN News, Syndication Comments Off on STAT+: AI drug developers Recursion, Exscientia to merge

Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia, said they will merge into one company.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

  • utah
  • UTNews
Previous

Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Next

Over 500,000 Trees Planted at Kealakekua Mountain Reserve on Hawaii’s Big Island

Related Articles

No Picture
News

Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

November 30, 2023 UCBN News, Syndication Comments Off on Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

PARK CITY, Utah, Nov. 30, 2023 /PRNewswire/ — Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise delivery […]

No Picture
News

Lipocine’s postpartum depression drug fails; AstraZeneca claims liver cancer win

April 2, 2026 UCBN News, Syndication Comments Off on Lipocine’s postpartum depression drug fails; AstraZeneca claims liver cancer win

Plus, news about Celldex and Pfizer: 📉 Lipocine’s Phase 3 fail: The Utah biotech’s stock {$LPCN} fell 77% after it said its oral brexanolone drug, called LPCN 1154, didn’t show … Click here to view […]

No Picture
News

SUU/BZI Youth Engineering Academy Grows More Than Six-Fold in Three Years, Significantly Increasing Opportunities and Positive Influence on K-12 STEM Students and Innovators of the Future

August 14, 2025 UCBN News, Syndication Comments Off on SUU/BZI Youth Engineering Academy Grows More Than Six-Fold in Three Years, Significantly Increasing Opportunities and Positive Influence on K-12 STEM Students and Innovators of the Future

KANARRAVILLE, Utah–(BUSINESS WIRE)– #GirlsinSTEM–SUU/BZI Youth Engineering Academy Grows More Than Six-Fold in Three Years, Significantly Increasing Opportunities for K-12 STEM Students Click here to view original post Click Here to Publish/Feature Your Company or Product […]

Advertise With Biotech Networks

Copyright © 2026 Biotech Networks

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox